Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants
This study has been completed.
Sponsor:
University of Plymouth
Information provided by:
University of Plymouth
ClinicalTrials.gov Identifier:
NCT00127465
First received: August 4, 2005
Last updated: December 10, 2008
Last verified: August 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Objective: To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing.
Design: Randomised trial with 8 groups (three factors, 2X2X2). Data collected at recruitment and three month follow-up.
Participants: 400 patients starting radiotherapy and their 'confidant' (the person in who they confide).
Interventions: Printed booklets.
- Half had 'general' CancerBACUP information for that cancer; half had 'personal' information from the medical record plus selected general information;
- Half chose information by 'interacting' with the computer; half had a larger volume of material in booklets that were produced 'automatically'.
- Half had additional 'anxiety management advice'.
Outcomes: Patients' views; use of booklet with others; change in reported social support; change in anxiety and depression.
| Condition | Intervention | Phase |
|---|---|---|
|
Breast Neoplasms Prostatic Neoplasms Laryngeal Neoplasms Cervix Neoplasms |
Procedure: Issue of information booklet |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Open Label |
| Official Title: | Investigating the Impact of Tailored Reports on Anxiety |
Resource links provided by NLM:
Further study details as provided by University of Plymouth:
Primary Outcome Measures:
- patients' views three months after intervention
- use of booklet with others between intervention and three month follow up
- change in reported social support between recruitment and three month follow up
- change in anxiety and depression between recruitment and three month follow up
Secondary Outcome Measures:
- confidants' views three months after intervention
- change in confidants' anxiety and depression between recruitment and three month follow up
| Estimated Enrollment: | 400 |
| Study Start Date: | November 2001 |
| Estimated Study Completion Date: | July 2003 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients starting outpatient radiotherapy treatment with breast, prostate, cervical or laryngeal cancer
Exclusion Criteria:
- Receiving palliative care
- Severe pain or symptoms causing distress
- Having cancer at other sites
- Having no spoken English
- Receiving treatment for psychological or psychiatric problems
- Visual or mental handicap
- Having case notes not available or ambiguous or illegible.
Contacts and Locations
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00127465 History of Changes |
| Other Study ID Numbers: | ESRC-L328253025 |
| Study First Received: | August 4, 2005 |
| Last Updated: | December 10, 2008 |
| Health Authority: | United Kingdom: National Health Service |
Keywords provided by University of Plymouth:
|
Medical Informatics Patient education Social support Cancer Anxiety |
Additional relevant MeSH terms:
|
Anxiety Disorders Breast Neoplasms Neoplasms Uterine Cervical Neoplasms Laryngeal Neoplasms Prostatic Neoplasms Mental Disorders Neoplasms by Site Breast Diseases Skin Diseases Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms |
Uterine Cervical Diseases Uterine Diseases Genital Diseases, Female Otorhinolaryngologic Neoplasms Head and Neck Neoplasms Laryngeal Diseases Respiratory Tract Diseases Respiratory Tract Neoplasms Otorhinolaryngologic Diseases Genital Neoplasms, Male Genital Diseases, Male Prostatic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013